PM360

APRIL 22, 2024

In this context, we shouldn’t just think of the Sacklers and Shkrelis and Holmeses of the world, who coupled regulatory noncompliance with lamentable ethical failures. With healthcare professionals becoming less accessible to biopharma reps, the emphasis has shifted toward patient empowerment.

Patients 52

Patients Biopharma Ethics Marketing 52

PM360

JUNE 24, 2024

This fuels an enormous need for effective patient communication and education as new therapies move through the biopharma pipeline. Those of us in the biopharma industry know how fraught drug development can be. As the saying goes, they are individually rare but collectively common. Many people, cumulatively, are affected.

Marketing 52

Marketing Patients Food and Drug Administration Digital Media 52

pharmaphorum

OCTOBER 11, 2022

Deeming this junctural moment in time as being the stage of “the stethoscope of the 21st century”, he urged the audience to understand that “data has no power to stir the soul”, rather, he said: “It’s not about the data, it’s about the human ethic.”. NB: Part 2 of ’Reuters Pharma 2022 – a day one overview’ will follow shortly….

Pharma 98

Pharma Patients Medicine Healthcare 98

Clarivate

FEBRUARY 5, 2024

They have no ethics. They’re wonderful for compiling data but they have no ethics. Human beings that have worked in this field are going to have to be able to establish guidelines and ethical standards and to curate these outputs in a manner that includes things like diverse populations.

Ethics 52

Ethics Medicine Government Consulting 52

PM360

JUNE 24, 2024

Yet from a risk-mitigation perspective, we anticipate a cautious, measured approach by most biopharma companies. A Bonus for Authenticity As biopharma professionals begin to routinely implement AI solutions, one thing we should all watch out for is how unique our work outputs are really going to be.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

Clarivate

MARCH 17, 2022

Margolis Center for Health Policy to convene a February 2021 public meeting about scientific and ethical issues associated with enrolling pregnant individuals in clinical trials for drug development. To this end, the agency collaborated with the Duke University Robert J.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

MedCity News

SEPTEMBER 20, 2023

While the benefits of generative AI are evident, ethical considerations and regulatory challenges are to be considered throughout the journey. With conscious and ethical use of Generative AI we can forge a future that is empathetic, innovative and can meet all our needs at the right time and place. Photo: metamorworks, Getty Images

Ethics 298

Ethics Medicine Pharmaceutical Pharmaceutical research 298

PM360

SEPTEMBER 30, 2024

In late 2023, Deloitte found that over half of 105 surveyed global biopharma leaders were committed to reducing environmental impact and advancing sustainability by minimizing water use, sourcing sustainable materials, and overhauling supply chains.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Clarivate

NOVEMBER 13, 2023

We developed or explored over 100 COAs and achieved ethical approval in multiple countries including the U.S., Last year alone the Clarivate COA team conducted over 300 interviews with patients, caregivers or healthcare professionals. Mainland China and Japan.

Patients 52

Patients Food and Drug Administration FDA Safety 52

PM360

JUNE 11, 2022

Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs. I appreciate companies that are ethical, stable, financially transparent, and who have their potential customers’ best interests at stake.

Patients 59

Patients Pharma Education Media 59

Clarivate

OCTOBER 7, 2024

Then, of course, there are the ethical considerations. For example, one study demonstrated 89% accuracy of in silico drug trials in populations of human cardiomyocyte models in predicting clinical arrhythmia — versus a 75% accuracy using animal models (Passini, 2017).

Food and Drug Administration 52

Food and Drug Administration Pharmacology Food Engineering 52